Rapamycin, an mTOR inhibitor used in autoimmune diseases and cancers also improves autophagy deficiency (Su et al., 2018) and has renal protective effects in DKD (Yang et al., 2007; Mori et al., 2009). The gene discussed is MTOR; the disease is diabetic kidney disease.